DocGo Shares Surge 32.5% as SteadyMD Buyout Fuels Telehealth Ambitions

DocGo Inc (NASDAQ: DCGO) Overview

DocGo Inc is a mobile healthcare company that provides on-demand clinical services outside traditional hospital settings. Formed in November 2021 through the merger of Ambulnz and Motion Acquisition Corp, the company trades on the NASDAQ under the ticker DCGO. DocGo's technology platform and network of licensed clinicians support population health programs, value-based payer arrangements, medical transportation, and in-home care designed to reduce the need for acute-care facilities.

Corporate Structure and Experience

Headquartered in New York, DocGo employs between 5,001 and 10,000 staff across clinical operations, technology, product development, sales, and administration. Care is provided by licensed EMTs, paramedics, and practical nurses, supported by an AI-powered ordering and management system known as Dara. Since its founding as Ambulnz in 2015, the company has expanded into 28 U.S. states and has served over 10 million patients through partnerships with hospital systems, governments, and private payers.

Mobile healthcare by National Cancer Institute

Developments and News

In October 2025, DocGo completed the acquisition of SteadyMD, a telehealth platform operating in all 50 states. The integration of SteadyMD’s services with DocGo’s mobile care capabilities aims to create a cohesive care delivery system, facilitating transitions between in-home visits and online consultations.

At the NCQA Health Innovation Summit held from October 13 to 15, 2025, DocGo presented enhancements to its in-home visit services, featuring new functionalities in the Dara platform, such as improved trip search capabilities, refined filters, and standardized documentation shaped by feedback from hospital dispatch teams. On October 19, 2025, DocGo participated in the Making Strides Against Breast Cancer Walk in Central Park, contributing to research and awareness efforts.

Financial and Strategic Analysis

On October 21, 2025, DocGo shares closed at $1.59, reflecting a 32.50% increase on a trading volume of 15,014,338 shares. The company’s revenue grew from approximately $11 million in 2016 to $440 million by 2022. Following the conclusion of a $432 million emergency contract for migrant housing in April 2024, DocGo shifted its focus toward collaborations with payers. Existing agreements include EmblemHealth, Blue Cross Blue Shield of Tennessee, UnitedHealthcare, Aetna, Elevance Health, Cigna, and L.A. Care. The SteadyMD acquisition and ongoing investments in its platform support DocGo’s strategy to diversify revenue streams by integrating telehealth and mobile services within value-based care models.

Market Position and Industry Context

DocGo competes in the expanding mobile health and non-emergency medical transportation sector by offering a technology-enabled alternative to traditional healthcare delivery models. Its services, which include in-home visits, remote patient monitoring, and ambulance services, align with the demand for cost-effective, patient-centered care. The broader healthcare industry's shift toward outpatient care and value-based arrangements supports DocGo's partnerships with payers and providers. By leveraging proprietary software and data analytics, the company aims to reduce hospital readmissions and further population health objectives in both urban and rural settings.

tl;dr

On October 21, 2025, DocGo shares increased 32.50% to $1.59, with over 15 million shares traded. In October 2025, the company acquired SteadyMD to incorporate telehealth into its mobile services. After concluding a $432 million migrant-housing contract in April 2024, DocGo has focused on payer partnerships and platform enhancements. The firm intends to scale its mobile and virtual care offerings through the Dara system and expanded agreements with insurers throughout 2025.